Form 4: ANI Pharmaceuticals SVP, Generics, Ori Gutwerg, Reports Tax-Related Stock Transaction
SEC Form 4 Filing
Ori Gutwerg, SVP, Generics at ANI Pharmaceuticals, reports the withholding of shares for tax purposes related to the vesting of restricted stock.
Summary
- On March 7, 2024, Ori Gutwerg, SVP, Generics at ANI Pharmaceuticals, reported a transaction involving common stock.
- 2,494 shares were disposed of to cover tax obligations related to the vesting of 6,476 shares of restricted stock.
- The price per share for the transaction was $66.71.
- Following the transaction, Gutwerg directly owns 80,212 shares of ANI Pharmaceuticals.
- The transaction was conducted under Rule 16(b)-3, which exempts certain tax-related transactions.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to stock transactions for tax purposes, and does not contain information that would significantly impact investor sentiment.
Industry Context
Form 4 filings are standard practice for corporate insiders to report transactions in their company's stock, providing transparency to the market.
Key Dates
| Date | Description |
|---|---|
| 03/07/2024 | Date of stock transaction (disposal of shares for tax purposes). |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.